Jordan Zwick
Förmögenhet: 454 820 $ per 2026-09-30
Förmögenhet: 454 820 $ per 2026-09-30
Mr. Jordan Zwick is a Venture Partner at ARCH Venture Partners LLC, an Independent Director at Palisade Bio, Inc. and an Independent Director at Theratechnologies, Inc. He is on the Board of Directors at Palisade Bio, Inc. and Theratechnologies, Inc. Mr. Zwick was previously employed as a SVP-Corporate Business Development by Amarin Corp.
Plc, a Head-Strategy by Salix Pharmaceuticals Ltd., a Trading Associate by Raymond James & Associates, Inc., and a Chief Strategy Officer by InflaRx NV.
He received his undergraduate degree from Florida Atlantic University, a graduate degree from Florida Atlantic University and an MBA from the University of San Francisco.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
PALISADE BIO, INC. 0,2 % | 2026-06-10 | 336 904 ( 0,2 % ) | 454 820 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| THERATECHNOLOGIES INC. | Direktör/Styrelseledamot | 2024-03-21 |
| PALISADE BIO, INC. | Direktör/Styrelseledamot | 2026-06-10 |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Privat kapitalinvesterare | 2026-07-01 |
| Företag | Position | Slut |
|---|---|---|
| AMARIN CORPORATION PLC | Företagsledare/Principal | 2023-01-01 |
| INFLARX N.V. | Företagsledare/Principal | 2022-06-29 |
| SALIX PHARMACEUTICALS, LTD. | Företagsledare/Principal | 2020-01-01 |
Raymond James & Associates, Inc.
Raymond James & Associates, Inc. Investment Banks/BrokersFinance Provides brokerage services | Företagsledare/Principal | 2009-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
Amarin Corp. Plc
Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Salix Pharmaceuticals Ltd.
Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company for the prevention and treatment of gastrointestinal diseases & disorders | Health Technology |
Raymond James & Associates, Inc.
Raymond James & Associates, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Theratechnologies, Inc.
Theratechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Florida Atlantic University
Florida Atlantic University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Francisco
University of San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InflaRx NV
InflaRx NV BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Palisade Bio, Inc.
Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån